Investors
Board and leadership
Key to committees/roles:
- E Executive
- N Nomination
- A Audit and Risk
- R Remuneration
- Chair
Luba Greenwood
Non-Executive Director
Appointment: 12 September 2022
Background/current external appointments: Luba Greenwood has served as a member of our board since September 2022. Ms. Greenwood has held a number of leadership and board positions in the healthcare, biotech, and digital health industries. Currently, Ms. Greenwood is the managing partner of the Dana Farber Cancer Institute Venture Fund, Binney Street Capital (“BSC”), a venture fund she has built and launched, and she is also the CEO of Kojin Therapeutics, a BSC portfolio company. In addition she is a Non-Executive Director of Massachusetts Biotechnology Council, Inc., BenchSci, and In8Bio Inc. Ms. Greenwood has held leadership positions at Google Life Sciences and at F. Hoffman-La Roche, from 2018 to 2019 and 2015 to 2018, respectively. She is currently a lecturer in engineering sciences at Harvard University, since 2019. Ms. Greenwood holds a law degree from Northeastern University School of Law.
Registered Office:
Discovery Drive, Cambridge
Biomedical Campus,
Cambridge, CB2 0AX, UK
+44 (0) 1223 696 000
VIEW PRODUCTS
© Abcam Limited. all rights reserved.
Abcam Limited is incorporated in England and Wales, its main country of operation in the UK. Use of this website is subject to our Terms and Conditions of use and our Privacy Policy. Share price and news information on this site is updated dynamically from external data feeds.
